REGULATION OF PLATELET INTEGRIN FUNCTION
血小板整合素功能的调节
基本信息
- 批准号:8051818
- 负责人:
- 金额:$ 49.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:BindingBinding SitesBiologicalBlood PlateletsCell surfaceCellsComputing MethodologiesConflict (Psychology)CoupledCytoplasmic TailDataDissociationEquilibriumFigs - dietaryIntegral Membrane ProteinIntegrin alpha ChainsIntegrinsLigand BindingMediatingMethodsModelingMolecularMolecular ConformationMutationPeptidesPhysiological ProcessesPlatelet InhibitorsRegulationRelative (related person)RoleTalinTestingTherapeuticTransmembrane DomainWorkbasedesignextracellularinsightresearch studysynthetic peptide
项目摘要
Integrins reside on cell surfaces in an equilibrium between inactive and active conformations. Thus, shifting
the equilibrium towards the inactive conformation will decrease integrin activity, whereas stabilizing the
activated conformation will increase activity. Integrin transmembrane domains interact heteromerically when
integrins are inactive and homomerically following activation. Accordingly, physiologic processes that
destabilize heteromeric interactions or stabilize homomeric interactions would be expected to induce integrin
activation. The work proposed in this application continues our examination of the relationship between
transmembrane domain interactions and integrin function by integrating cell biological, molecular biological,
and biophysical methods. The studies focus on the platelet integrin alpha-llb-beta3. In Specific Aim 1. we will
characterize the helical interfaces that mediate the heteromeric and homomeric interactions of the alpha-llb and
beta3 transmembrane domains. We have shown that a GxxxG motif in the alpha-llb transmembrane helix is
essential for its homomeric interactions. The motif also likely participates in the heteromeric interaction of
alpha-llb with beta3, but the identity of other alpha-llb residues that participate in this association are not known. The
information available about the beta3 residues involved in its heteromeric and homomeric interactions is limited
and conflicting. The data obtained from the proposed studies will be used to construct models of integrin
transmembrane domain oligomers using computational methods and to determine the relative contribution of
heteromeric and homomeric interactions in regulating alpha-llb-beta3 function using transfected cells. Lastly, the
participation of cytoplasmic domain sequences in stabilizing transmembrane domain interactions will be
considered. Specific Aim 2 is based on observations that synthetic peptides can be designed to modulate
the assembly of transmembrane proteins. The proposed experiments will provide additional insight into the
role of TM helix interactions in alpha-llb-beta3 activation and proof of principle for the use of synthetic transmembrane
domain peptides as anti-thrombotic agents.
整合素以非活性构象和活性构象之间的平衡存在于细胞表面。因此,转移
朝向无活性构象的平衡将降低整联蛋白活性,而稳定整联蛋白活性,
活化构象将增加活性。整合素跨膜结构域异聚体相互作用时,
整联蛋白是无活性的,并且在活化后是同聚的。因此,
使异聚体相互作用不稳定或使同聚体相互作用稳定预期会诱导整联蛋白
activation.在本申请中提出的工作继续我们的研究之间的关系,
通过整合细胞生物学,分子生物学,
和生物物理学方法。这些研究集中在血小板整合素α-IIb-β 3。具体目标1。我们将
表征介导α-IIb的异聚和同聚相互作用的螺旋界面,
β 3跨膜结构域。我们已经表明,在α-IIb跨膜螺旋中的GxxxG基序是
对于其同质异构体相互作用至关重要。该基序也可能参与了
α-IIb与β 3结合,但参与这种结合的其他α-IIb残基的身份尚不清楚。的
关于β 3残基参与其异聚体和同聚体相互作用的信息有限
和冲突。从拟议的研究中获得的数据将用于构建整合素模型
使用计算方法分析跨膜结构域寡聚体,并确定跨膜结构域寡聚体的相对贡献
使用转染细胞调节α-IIb-β 3功能的异聚体和同聚体相互作用。最后
胞质结构域序列在稳定跨膜结构域相互作用中的参与将是
考虑了具体目标2是基于这样的观察,即合成肽可以被设计成调节
跨膜蛋白的组装。拟议的实验将提供更多的见解,
TM螺旋相互作用在α-IIb-β 3活化中的作用和使用合成跨膜
结构域肽作为抗血栓形成剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOEL BENNETT其他文献
JOEL BENNETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOEL BENNETT', 18)}}的其他基金
相似海外基金
Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
- 批准号:
24K15172 - 财政年份:2024
- 资助金额:
$ 49.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
- 批准号:
23K04928 - 财政年份:2023
- 资助金额:
$ 49.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
- 批准号:
10744934 - 财政年份:2023
- 资助金额:
$ 49.81万 - 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
- 批准号:
573688-2022 - 财政年份:2022
- 资助金额:
$ 49.81万 - 项目类别:
University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10704557 - 财政年份:2022
- 资助金额:
$ 49.81万 - 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10537846 - 财政年份:2022
- 资助金额:
$ 49.81万 - 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
- 批准号:
2753921 - 财政年份:2022
- 资助金额:
$ 49.81万 - 项目类别:
Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
- 批准号:
10328140 - 财政年份:2022
- 资助金额:
$ 49.81万 - 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
- 批准号:
10621368 - 财政年份:2021
- 资助金额:
$ 49.81万 - 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
- 批准号:
2111821 - 财政年份:2021
- 资助金额:
$ 49.81万 - 项目类别:
Standard Grant